Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Coherus Oncology (CHRS) Cash from Investing Activities (2016 - 2025)

Coherus Oncology (CHRS) has disclosed Cash from Investing Activities for 13 consecutive years, with -$2.8 million as the latest value for Q4 2025.

  • Quarterly Cash from Investing Activities fell 423.62% to -$2.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $375.1 million through Dec 2025, up 62.85% year-over-year, with the annual reading at $375.1 million for FY2025, 62.85% up from the prior year.
  • Cash from Investing Activities hit -$2.8 million in Q4 2025 for Coherus Oncology, up from -$67.2 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $462.6 million in Q2 2025 to a low of -$285.5 million in Q1 2021.
  • Historically, Cash from Investing Activities has averaged $22.2 million across 5 years, with a median of $8.2 million in 2021.
  • Biggest five-year swings in Cash from Investing Activities: plummeted 17565.53% in 2021 and later skyrocketed 11160.39% in 2023.
  • Year by year, Cash from Investing Activities stood at $107.5 million in 2021, then plummeted by 220.85% to -$129.9 million in 2022, then skyrocketed by 127.1% to $35.2 million in 2023, then crashed by 101.54% to -$542000.0 in 2024, then tumbled by 423.62% to -$2.8 million in 2025.
  • Business Quant data shows Cash from Investing Activities for CHRS at -$2.8 million in Q4 2025, -$67.2 million in Q3 2025, and $462.6 million in Q2 2025.